Although this contradiction may be influenced by the cancer stage or context [125], it provides opportunities for future studies to ascertain the molecules or intermediates in AR signaling that are modulated by SIRT1 in favor of the progression of prostate cancer. Here, SIRT1 is linked to prostate carcinoma.